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ABSTRACT
Sickle cell anemia is one of the most common inherited diseases worldwide. It is believed that quality of
life (QoL) of the sickle cell patient is very low and that in its general socio-economic conditions and
cultural well indicate lack in several aspects. The objective this study was to describe and analyze the
QoL of patients with sickle cell anemia In a Hematology clinic of a teaching hospital in Southeastern
Brazil. This is a cross-sectional study with application of the WHOQOL-BREF instrument, on the four
domains, in adults (group 1) and children (group 2) carriers of sickle cell anemia. In the calculation of
differences between proportions was employed the chi-square test. To check for differences between the
means was used the Student t test for independent samples. For analysis of association between
variables, we used prevalence ratio (PR) with its confidence interval at 95% (CI 95%), as estimates of
magnitude. A significance level of 5% was considered in all analysis. In group 1 were selected 27
patients (54%) with mean age of 27.2 years old and 58.3% female, while in group 2 were 23 children
(46%) whose mean age was 8.7 years old, with 57.1% of the sample consisted of male patients. QoL
was higher among patients of the group 2 in physical and environmental domains (p <0.05). The popu-
lation studied presented a favorable QoL, with means above 11 in all domains. Patients aged ? 13 years
old had better QoL compared to > 13 years, possibly indicating better physical functioning and less
psychological conflicts.
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Introduction
Sickle cell disease is one of the most common
inherited diseases worldwide, affecting mainly the black
population. The World Health Organization (WHO)
estimates that each year are born in Brazil between
700 and 1000 children with sickle cell anemia.1,2 Be-
cause it is the most prevalent hereditary disease in the
country, and frequently present delayed diagnosis with
high morbidity and mortality, sickle cell anemia should
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be considered a public health problem in Brazil and in
the world.3,4,5
It is believed that patients with sickle cell dis-
ease has a quality of life (QoL) very low and that their
overall socio-economic and cultural deficiency also
point to several aspects,6,7 so that the they has a better
health status and QoL is needed proper guidance and
assistance, both in medical and psychosocial terms, as
well as studies that address the public health aspects.
Aiming to contribute to improving the care pro-
vided to these patients came to the conclusion that a
study of QoL allow to identify the factors that influ-
ence the welfare of these people, determine the
changes necessary to achieve their well-being, set
magnitude of the problems of population, provide con-
ditions for their rehabilitation and the sickle cell ad-
dress in a comprehensive manner while focusing on
their clinical symptoms with its psychosocial aspects,
in order to improve their health and quality of life.
Based on this, the objective this study was to describe
and analyze the QoL of patients with sickle cell dis-
ease followed at the Hematology clinic, according to
the WHOQOL-BREF8,9 in the domains: physical, psy-
chological, social relationships and environment.
Methods
This is a cross-sectional study in which the se-
lected population consisted of patients with sickle cell
disease followed at the Hematology Clinic of the Re-
gional Blood Center of Federal University of Triangulo
Mineiro (FUTM)-Brazil during 2010. Data were col-
lected through the application of two instruments: the
first for the characterization of the socio-demographic
data, clinical and epidemiological (age, origin, marital
status, education, income, occupation, physical activ-
ity, crises of pain, achievement of transfusion, medi-
cation and other disorders [Diabetes, bleeding, smok-
ing among others]), and second, measurement of QoL,
using the WHOQOL-BREF, proposed by the World
Health Organization (WHO),8 validated version in
Portuguese.9 The WHOQOL-BREF instrument has
26 facets, which, comprising four domains: physical,
psychological, social relationships and environment.
Inclusion criteria
We selected patients with sickle cell anemia,
treated in outpatient settings, with no record of severe
comorbidities, who agreed to participate. The sample
was composed of two different populations, forming
two groups: Group 1, consisting of adolescent and adult
patients older than 13 years and Group 2 consisted of
children and adolescents younger than 13 years.
Exclusion criteria
Patients and/or guardians who have not agreed
to participate in the study were ineligible. Patients who
were eligible, but which had severe comorbidities were
excluded.
Statistical analysis
The questionnaires were entered in Excel soft-
ware, and stored with tabulation, consolidation and
analysis employing the software Epi-Info 6.04 and
SPSS® version 20 in the syntax of the WHOQOL-
BREF. The highest scores corresponded to better qual-
ity of life, and after processing the syntax, the values
of domains and facets ranging from four to 20. In the
calculation of differences between proportions was
employed the chi-square test. To check for differences
between the means was used the Student t test for
independent samples. When we chose to investigate
the distribution and differences between median was
used the Kruskal-Wallis test. For analysis of associa-
tion between variables, we used prevalence ratio (PR)
with its confidence interval at 95% (CI 95%), as esti-
mates of magnitude. A significance level of 5% was
considered in all analysis.
Ethical aspects
The research project was reviewed and ap-
proved by the Research Ethics Committee of the
FUTM, (Number 0823). Before the study began, the
interviewer presented the objectives of the study to
patients and requested their participation. Only after
the consent of the interviewee and signing the con-
sent form, there was an application of the question-
naire.
Results
We interviewed 50 patients with sickle cell
anemia, 27 (54%) aged over 13 years and 23 in group
? 13 years. Among those over 13 years old, the mean
age was 27.2 (± 8.3) years, minimum 15 and maxi-
mum of 40 years. Among children the mean age was
8.7 (± 3.5) years, ranging from two to 13 years old. In
the adult group, 41.7% of patients were male, while
among children, were 57.1% (Table 1), no significant
difference (PR 0.73, [95% 0.4 to 1.3]).
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In group 1, 92.6% were unmarried, 3.7% mar-
ried and 3.7% separated. In the same group, 37.0%
of patients were attending school at the time of data
collection, with the majority of patients presented el-
ementary education level, 33.3% of cases. Only five
patients had tertiary education. With regard to family
income, the majority of patients (48.4%) had low
monthly income. Most respondents (92.6%) lived with
their relatives. Regarding the frequency of pain cri-
ses, the majority (48.1%) said they rarely have them,
no difference was observed between adults and chil-
dren (PR = 1.57 [95% CI 0.38 to 6.40], p = 0.45).
With regard to the intensity of pain crises, 40.7% of
patients reported that their attacks are strong, while
25.9% reported being very strong and moderate, re-
spectively, while only 3.7% of patients reported hav-
ing pain of low and very low intensity, respectively.
When analyzing the responses of adults and children,
it is observed that there was no difference (PR = 1.01
[95% CI 0.84 to 1.22], p = 0.64). When there is a
report of blood transfusion, it is observed that among
adults, the event was recorded in 95.8% of patients,
while among children the same occurred in 85.7% of
cases, with no difference between both groups (PR =
1.12 [95% CI 0.92 to 1.36], p = 0.32). On the use of
medicines due to illness, 95.8% of adult patients and
90.5% of children reported use, especially folic acid
and analgesics, with no differences between the two
groups (PR = 1.06 [95% 0.90 to 1.25], p = 0.59). Re-
garding co-morbidity, most (33.3%) declared not to
present, while 25.9% reported more than one co-mor-
bidity, with no difference in the prevalence among
adults and children (PR = 0.93 [ 95% CI 0.52 to 1.64],
p = 0.94). When analyzing the physical activity, we
found that among adults the report was positive in
29.2% of respondents, while among children was
42.8%, however, no difference was found between
the prevalence of two groups (PR = 0.68 [95% CI
0.31 to 1.51], p = 0.51]).
Evaluation of QoL
In group 1, most patients (51.9%) judged their
quality of life as good. About satisfaction with their
health, 48.1% said they were satisfied or very satis-
fied. Regarding the influence of physical pain in car-
rying out activities, 44.4% of patients considered that
this prevents them enough. About 48.0% of respond-
ents stated that they need a lot of medical treatment
to bring your daily life. Around 37.0% of said selected
rather enjoy life and when asked about the extent to
which life has meaning, the same percentage consid-
ered as having extreme sense.
With respect to the concentration, 44.4% re-
ported able to concentrate on more or less. About se-
curity in their daily lives, 40.7% of patients were con-
sidered safe enough. With respect to the physical en-
vironment, 33.3% of respondents said it is more or
less healthy, while 37.0% thought nothing or very little
insurance and 29.6% considered it very or extremely
healthy. Regarding the willingness and energy for the
day to day, the majority (44.4%) stated that average
amount of the attribute. Regarding the acceptance of
physical appearance, 70.3% considered to agree very
well or completely. About the amount of money to meet
the needs, 37.0% of patients said they had very little
money, while only 18.5% said they very or quite satis-
fied. Most adults (40.7%) considered to have an avail-
ability of information needed for day to day. When
asked about the opportunity of leisure activities, 48.1%
had little or no opportunity. As to walking ability, 51.8%
of patients said to move well or very well. Regarding
sleep satisfaction, 48.1% thought they were satisfied.
On the ability to perform day-to-day, the majority
(44.4%) reported being satisfied. In relation to satis-
faction with personal relationships (friends, relatives,
acquaintances, colleagues), 44.4% considered them-
selves satisfied, and being that same percentage was
found as they researched to satisfaction with sex life,
that is, the majority stated be satisfied. More than half
Table 1
Characteristics of the biological variables among
adults and children with sickle cell disease as-
sisted in the hematology ward, FUTM-2010.
Group
Variables Adults Childrens P value
N  (%) 27 (54) 23 (46) >0,05*
Age (years)
(Mean ± PD) 27,2 (± 8,3) 8,7 (± 3,5) <0,05#
(max - min) (15 - 40) (2 - 13)
Sex
Male - N (%) 11 (41,7) 13 (57,1) >0,05*
Female - N (%) 16 (58,3) 10 (42,9) >0,05*
* Z test; # t' Student test
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economic characteristics of the study population are
consistent with the literature, since the majority of re-
spondents reported having an income below two mini-
mum wages and low education. The fact that this work
was done in a public service where the medical as-
sistance is made solely by the Brazilian Health Uni-
fied System (HUS), may have contributed to this find-
ing.
The clinical manifestations of disease usually
appear after six months of life, extending over a life-
time and show great variability. The main clinical mani-
festations are painful crises.5,14 Most patients said they
rarely have any pain crises, contradicting what is in
the world literature,5,10 however, our findings may re-
flect an appropriate medical monitoring, as well as
patient compliance due to greater availability of ef-
fective treatment and also currently offered by spe-
cialized services.
Patients with sickle cell disease have a chronic
anemia which is associated with a greater capacity
for oxygen release by hemoglobin S, allowing them to
be mildly symptomatic in relation to anemia and do not
require a routine red blood cell transfusion, which is
held usually in the presence of acute complica-
tions.15,16,17 According to the results, the majority of
patients with sickle cell disease, stated that had deter-
mined frequency of blood transfusion, showing that
the use of this procedure is not periodic for most re-
spondents, which may be due to the effectiveness of
drug treatment and monitoring. So, how in the world
literature, this study showed that blood transfusion in
patients with sickle cell disease is most often used to
treat acute and not a routine therapeutic use.
of respondents (55.5%) reported being satisfied or
very satisfied with the access to health services.
When comparing the physical (Domain 1), psy-
chological (Domain 2), social relationships (Domain
3) and environment (Domain 4), between adults and
children, can be observed that there were differences
between groups in physical and environment domains,
whose values were significantly higher among patients
aged below 13 years (Table 2), the same was found
when comparing the overall QoL.
As for the psychological and social relations
were no significant differences between the two
groups.
Discussion
In this study, the oldest respondent was 40 years
old, being within the current life expectancy of the
U.S. population with sickle cell anemia which is 42
years for men and 48 years for women.2,10 According
to the literature, mortality is higher in the first two years
of life, and infections, especially bacterial, the main
causes.10,11 In group 2 of the study, in which the young-
est patient was two years old, we cannot be said that
there was an even higher mortality in this age popula-
tion, therefore, was not taken into account in the meth-
odology of this study, tracking patients and the lifting
of those who died, so it was not possible to verify this
outcome or association.
Sickle cell anemia primarily affects black peo-
ple12 that historically in Brazil, are socio-economically
disadvantaged.13 Although this study did not take into
account issues of race, we can say that the socio-
Table 2
Distribution of mean values of the domains of QoL (WHOQOL-BREF) in adults and children with
sickle cell disease assisted in the hematology ward, FUTM-2010.
Mean (± PD)
Group
Domain > 13 years old ≤ 13 years old P value
Physical 12.16 (± 2.77) 14.55 (± 1.72) < 0,05
Psychological 14.69 (± 2.55) 15.58 (± 2.59) > 0,05
Social Relationships 13.55 (± 4.42) 11.93 (±2.47) >0,05
Environment 11.95 (± 2.82) 13.64 (± 1.62) < 0,05
Overall QoL 11.96 (± 2.83) 13.65 (± 1.61) < 0,05
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In sickle cell disease there are few specific
therapeutic options,18,19,20 being fundamental institu-
tion of general and preventive measures to lessen the
consequences of chronic anemia, sickle cell crises, and
susceptibility to infections.21,22 Patients with sickle cell
disease have chronic hemolysis, and in an attempt to
compensate the anemia, there is an increased produc-
tion of red blood cells, which consume folic acid, so it
is recommended that supplementation with 1-2 mg of
folate daily. With respect to drug therapy of patients
studied, most reported about using folic acid.
Patients with sickle cell disease have increased
susceptibility to infections by capsulated organisms,
mainly due to loss of splenic function (auto-splenec-
tomy) due to frequent thrombosis and infarction,22 thus,
it is recommended prophylaxis with penicillin for all
children with sickle cell disease, should be made from
three months to five years old. You can use either orally
(penicillin V) or parenteral (benzathine penicillin). This
study included five patients aged less than five years,
but 11 patients in group < 13 years reported using peni-
cillin. In the group > 13 years of age, only one person
reported using penicillin. The use of penicillin prophy-
laxis in sickle cell outside the recommended age may
have been a medical management for individual pa-
tients in such service where the study was conducted.
Although physical activity is able to trigger pain-
ful crises, their practice is not formally contraindicated,
may be recommended if it is regular and moderate,
with the effort progresses slowly and under supervi-
sion.23 In the groups studied here, the majority stated
that physical activities. We can not say that this find-
ing is a contraindication, as the service that hosted the
study, this is not usual recommendation. Even having
the hereditary disease most prevalent in Brazil, the
national literature about the sickle cell disease, has lit-
tle research on aspects and impacts related to public
health. The issues most frequently raised about the
disease are associated with clinical and epidemiologi-
cal factors such as population prevalence studies.24,25
Because of this, difficulties were encountered in com-
paring the results of this study with other studies on
the subject, because we found no publications on quality
of life in patients with sickle cell disease in the Brazil-
ian literature.
When analyzing the contribution of different
domains in the QoL of the respondents, it was ob-
served that in both groups, the social and psychologi-
cal domains showed the highest, ie the mean values
were higher. Regarding the contribution of the physi-
cal domain for QoL, we observed that in patients ≤ 13
years old, this was higher than in patients > 13 years
(p<0.05). This could be explained by greater functional
capacity expected in the younger group of patients,
besides knowing the literature, that patients with longer
disease duration, ie those with higher age are more
intense and painful episodes more severe, thus lead-
ing a major limitation and disability.26,27,28 Another ex-
planation could be that the disease is well controlled
and thus interfere little in the physical aspects of those
younger patients.
In both groups the environmental domain was
the one with a smaller contribution in the QoL, how-
ever, group 2 had an average higher than group 1 (p
<0.05). This data can be correlated with the findings
of a socioeconomic questionnaire, where the majority
of patients reported having low purchasing power,
which may have contributed to less access to infor-
mation, less opportunity for leisure, less access to
health services, environment more physical harm,
among others. You can also, in some way infer that
the younger patients, like those in the group aged 13
years or less, have less awareness of environmental
issues as a component of QoL, increasing the values
when compared to patients older. Considering the range
of 4 to 20 for the syntax of QoL of the WHOQOL-
BREF, the social relationships, physical, psychological
and environmental values were above 11 in both
groups. It is considered that values above 11 expressed
a positive perception of the QoL. Patients younger
than or equal to 13 years showed higher average
scores in all domains rather than > 13 years old. This
result can be expected by the fact that respondents ≤
13 years old are generally less concerned with issues
of day-to-day, less accountability, better functional
capacity, among other aspects to be considered as bio-
logical and social.
Conclusion
When analyzing the results of the WHOQOL-
BREF, it follows that the population has a favorable
QoL, since they were found with mean values above
11 in all domains of the questionnaire. Furthermore, in
relation to overall QoL, most patients in both groups
evaluate their QoL as good. Patients aged ≤ 13 years
had better QoL compared to > 13 years, possibly indi-
cating better physical functioning and less psychologi-
cal conflicts. Regarding the clinical profile of patients
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studied, we conclude that the majority has controlled
disease, as it declared that rarely have pain crises, the
main manifestation of the disease. But the depend-
ence on medication for the disease was observed in
most patients.
Considering the socioeconomic profile, we con-
clude that the majority of the interviewees belong to
economically disadvantaged classes, as reported to
have low income and low education. Therefore, stud-
ies like this that are described in every socio-economic
and clinical-epidemiological study of a specific popu-
RESUMO
A anemia falciforme é uma das doenças hereditárias mais comuns em todo o mundo. Acredita-se que
a qualidade de vida (QV) do paciente com a doença falciforme é muito baixa e que suas condições
socioeconômicas e culturais indicam deficiências em vários aspectos. O objetivo deste estudo foi
descrever e analisar a QV dos pacientes com anemia falciforme assistidos em um ambulatório de
hematologia de um hospital de ensino no sudeste do Brasil. Este é um estudo transversal com aplica-
ção do instrumento WHOQOL-BREF em adultos (grupo 1) e crianças (grupo 2) com anemia falciforme.
No cálculo de diferenças entre proporções foi utilizado o teste do qui-quadrado. Para verificar diferenças
entre as médias foi utilizado o teste t de Student para amostras independentes. Para análise da asso-
ciação entre as variáveis, foi empregada a razão de prevalência (RP) com seu intervalo de confiança a
95% (IC95%), como estimadores de magnitude. Considerou-se um nível de significância de 5% em
todas as análises. No grupo 1 foram selecionados 27 pacientes (54%) com média de idade de 27,2
anos, sendo 58,3% do sexo feminino, enquanto que no grupo 2 foram 23 crianças (46%), cuja média de
idade foi de 8,7 anos, com 57,1% da amostra do sexo masculino. A QV foi maior entre os pacientes do
grupo 2 nos domínios físicos e ambiental (p<0,05). A população estudada apresentou uma QV favorável,
com valores médios acima de 11 em todos os domínios. Pacientes com idade ? 13 anos apresentaram
melhor QV em relação aos com idade > 13 anos, possivelmente indicando melhor funcionalidade e
menos conflitos emocionais e psicológicos.
Palavras-chave: Qualidade de Vida. WHOQOL-BREF. Anemia Falciforme. Adulto. Criança.
lation may be important for planning and implement-
ing actions in an attempt to improve the QoL of these
people.
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